Xiyong Yu
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Extracellular vesicles in disease 16
- Advanced biosensing and bioanalysis techniques 14
- RNA Interference and Gene Delivery 13
-
- Nanoplatforms for cancer theranostics 44
- Co-authors
- Hong Cheng (27 shared papers)Shiying Li (27 shared papers)Rongrong Zheng (22 shared papers)Linping Zhao (21 shared papers)Yangxin Li (15 shared papers)Lingmin Zhang (19 shared papers)Bin Liu (8 shared papers)Guiling Fan (11 shared papers)
- Journals
- Journal of Nanobiotechnology (7 papers)Biomaterials (7 papers)Acta Pharmaceutica Sinica B (6 papers)Advanced Healthcare Materials (5 papers)Journal of Colloid and Interface Science (4 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Xiyong Yu
127 papers receiving 4.5k citations
Xiyong Yu's Hit Papers
Peers
Comparison fields: 5 of 130
- Cancer Research 831
- Biomaterials 660
- Biomedical Engineering 1.8k
- Molecular Biology 2.3k
- Pharmaceutical Science 177
Countries citing papers authored by Xiyong Yu
This map shows the geographic impact of Xiyong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiyong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiyong Yu more than expected).
Fields of papers citing papers by Xiyong Yu
This network shows the impact of papers produced by Xiyong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiyong Yu. The network helps show where Xiyong Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiyong Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 223 | |
| 2 | 2020 | 204 | |
| 3 | Inflammasomes as therapeutic targets in human diseases Hit paper breakdown → | 2021 | 175 |
| 4 | 2020 | 156 | |
| 5 | 2020 | 150 | |
| 6 | 2018 | 148 | |
| 7 | Ribosome biogenesis in disease: new players and therapeutic targets Hit paper breakdown → | 2023 | 146 |
| 8 | 2019 | 145 | |
| 9 | 2022 | 140 | |
| 10 | 2019 | 137 | |
| 11 | 2018 | 130 | |
| 12 | 2019 | 123 | |
| 13 | 2019 | 123 | |
| 14 | 2020 | 102 | |
| 15 | 2019 | 98 | |
| 16 | 2017 | 88 | |
| 17 | 2022 | 74 | |
| 18 | 2022 | 73 | |
| 19 | 2021 | 68 | |
| 20 | 2019 | 65 |
About Xiyong Yu
Xiyong Yu is a scholar working on Molecular Biology, Biomedical Engineering, Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 132 papers that have together received 4.6k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (44 papers), Photodynamic Therapy Research Studies (19 papers), Extracellular vesicles in disease (16 papers), Advanced biosensing and bioanalysis techniques (14 papers), RNA Interference and Gene Delivery (13 papers), MicroRNA in disease regulation (11 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Peptidase Inhibition and Analysis (9 papers). The work is most often cited by research in Cancer Research (831 citations), Biomaterials (660 citations), Biomedical Engineering (1.8k citations), Molecular Biology (2.3k citations) and Pharmaceutical Science (177 citations). Xiyong Yu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Hong Cheng, Shiying Li, Rongrong Zheng, Linping Zhao, Yangxin Li, Lingmin Zhang, Bin Liu, Guiling Fan, Xiangbin Pan and Xiaozhong Qiu. Their work appears in journals such as Journal of Nanobiotechnology, Biomaterials, Acta Pharmaceutica Sinica B, Advanced Healthcare Materials and Journal of Colloid and Interface Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.